{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T04:49:42Z","timestamp":1768798182254,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T00:00:00Z","timestamp":1416441600000},"content-version":"vor","delay-in-days":1784,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.jvs.2009.07.119","type":"journal-article","created":{"date-parts":[[2009,10,18]],"date-time":"2009-10-18T04:17:54Z","timestamp":1255839474000},"page":"114-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization"],"prefix":"10.1016","volume":"51","author":[{"given":"Nikolaos P.E.","family":"Kadoglou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Sailer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anestis","family":"Moumtzouoglou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alkistis","family":"Kapelouzou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Gerasimidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos D.","family":"Liapis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2009.07.119_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/MAJ.0b013e31815b60a1","article-title":"The role of carotid plaque vulnerability and inflammation in the pathogenesis of acute ischemic stroke","volume":"336","author":"Ding","year":"2008","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jvs.2009.07.119_bib2","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJM199811123392002","article-title":"Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis","volume":"339","author":"Barnett","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvs.2009.07.119_bib3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1747-4949.2007.00123.x","article-title":"Imaging the cellular biology of the carotid plaque","volume":"2","author":"U-King-Im","year":"2007","journal-title":"Int J Stroke"},{"key":"10.1016\/j.jvs.2009.07.119_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.atherosclerosis.2007.11.036","article-title":"A three-dimensional ultrasonographic quantitative analysis of non-ulcerated carotid plaque morphology in symptomatic and asymptomatic carotid stenosis","volume":"198","author":"Heliopoulos","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jvs.2009.07.119_bib5","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1159\/000165110","article-title":"Quantitative evaluation of carotid plaque echogenicity by integrated backscatter analysis: correlation with symptomatic history and histologic findings","volume":"26","author":"Nagano","year":"2008","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jvs.2009.07.119_bib6","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1148\/radiol.2483071817","article-title":"Increasing carotid plaque echolucency is predictive of cardiovascular events in high-risk patients","volume":"248","author":"Reiter","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.jvs.2009.07.119_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jvs.2007.09.058","article-title":"The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerability","volume":"47","author":"Kadoglou","year":"2008","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2009.07.119_bib8","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ejvs.2007.12.011","article-title":"Intensive lipid-lowering therapy ameliorates novel calcification markers and GSM score in patients with carotid stenosis","volume":"35","author":"Kadoglou","year":"2008","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2009.07.119_bib9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/FJC.0b013e318165dcad","article-title":"Rapid stabilization of vulnerable carotid plaque within 1 month of pitavastatin treatment in patients with acute coronary syndrome","volume":"51","author":"Nakamura","year":"2008","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jvs.2009.07.119_bib10","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.ultrasmedbio.2008.01.019","article-title":"Statin therapy increases carotid plaque echogenicity in hypercholesterolemic patients","volume":"34","author":"Yamagami","year":"2008","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.jvs.2009.07.119_bib11","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s11883-009-0032-8","article-title":"Osteopontin: a multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification","volume":"11","author":"Cho","year":"2009","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jvs.2009.07.119_bib12","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1586\/14779072.4.6.801","article-title":"The osteoprotegerin\/RANK\/RANKL system: a bone key to vascular disease","volume":"4","author":"Kiechl","year":"2006","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.jvs.2009.07.119_bib13","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2143\/AC.63.5.2033230","article-title":"Increased plasma osteoprotegerin levels are associated with the presence and severity of acute coronary syndrome","volume":"63","author":"Ren","year":"2008","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.jvs.2009.07.119_bib14","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2174\/138161209787315729","article-title":"Pleiotropic effects of statins\u2013clinical evidence","volume":"15","author":"Athyros","year":"2009","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jvs.2009.07.119_bib15","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2009.07.119_bib16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/HCR.0b013e318192754e","article-title":"A review of lipid management in primary and secondary prevention","volume":"29","author":"Dembowski","year":"2009","journal-title":"J Cardiopulm Rehabil Prev"},{"issue":"4 Suppl","key":"10.1016\/j.jvs.2009.07.119_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejvs.2008.11.006","article-title":"ESVS guidelines","volume":"37","author":"Liapis","year":"2009","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2009.07.119_bib18","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jdiacomp.2007.12.008","article-title":"Cardiorespiratory capacity is associated with favourable cardiovascular risk profile in patients with Type 2 diabetes","volume":"23","author":"Kadoglou","year":"2009","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jvs.2009.07.119_bib19","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1148\/radiol.2292030516","article-title":"Carotid artery stenosis: gray-scale and Doppler US diagnosis\u2013Society of Radiologists in Ultrasound Consensus Conference","volume":"229","author":"Grant","year":"2003","journal-title":"Radiology"},{"key":"10.1016\/j.jvs.2009.07.119_bib20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1053\/ejvs.2000.1286","article-title":"Variability in measurement of internal carotid artery stenosis by arch angiography and duplex ultrasonography\u2013time for a reappraisal?","volume":"21","author":"Griffiths","year":"2001","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2009.07.119_bib21","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1046\/j.1440-1673.2001.00994.x","article-title":"Direct B-mode NASCET-style stenosis measurement and Doppler ultrasound as parameters for assessment of internal carotid artery stenosis","volume":"46","author":"Rotstein","year":"2002","journal-title":"Australas Radiol"},{"key":"10.1016\/j.jvs.2009.07.119_bib22","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2174\/157016108783955365","article-title":"Statins for the prevention of first or recurrent stroke","volume":"6","author":"Athyros","year":"2008","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.jvs.2009.07.119_bib23","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.amjcard.2008.10.029","article-title":"Incremental DEcrease through Aggressive Lipid Lowering Investigators","volume":"103","author":"Tikkanen","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jvs.2009.07.119_bib24","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial","volume":"285","author":"Schwartz","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2009.07.119_bib25","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1161\/STROKEAHA.108.534107","article-title":"Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial by stroke subtypes","volume":"40","author":"Amarenco","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.jvs.2009.07.119_bib26","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1161\/STROKEAHA.108.516450","article-title":"Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial","volume":"39","author":"Sillesen","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.jvs.2009.07.119_bib27","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/jama.291.9.1071","article-title":"Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial","volume":"291","author":"Nissen","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2009.07.119_bib28","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/hrt.2006.102848","article-title":"Comparison of intensive and low-dose atorvastatin therapy in the reduction of carotid intimal-medial thickness in patients with coronary heart disease","volume":"93","author":"Yu","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.jvs.2009.07.119_bib29","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/jama.297.5.499","article-title":"Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis","volume":"297","author":"Nicholls","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2009.07.119_bib30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/1074248408318628","article-title":"An overview of the extra-lipid effects of rosuvastatin","volume":"13","author":"Kostapanos","year":"2008","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.jvs.2009.07.119_bib31","doi-asserted-by":"crossref","first-page":"19676","DOI":"10.1074\/jbc.M606938200","article-title":"Osteopontin overexpression inhibits in vitro re-endothelialization via integrin engagement","volume":"282","author":"Leali","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jvs.2009.07.119_bib32","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/01.STR.0000129790.00318.a3","article-title":"Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis","volume":"35","author":"Golledge","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.jvs.2009.07.119_bib33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0021-9150(03)00298-3","article-title":"Plasma osteopontin levels are associated with the presence and extent of coronary artery disease","volume":"170","author":"Ohmori","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jvs.2009.07.119_bib34","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1161\/01.ATV.0000229701.42828.73","article-title":"Effect of atorvastatin on plasma osteopontin levels in patients with hypercholesterolemia","volume":"26","author":"Tanaka","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jvs.2009.07.119_bib35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/sj.bjp.0704046","article-title":"NK-104, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, reduces osteopontin expression by rat aortic smooth muscle cells","volume":"133","author":"Takemoto","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jvs.2009.07.119_bib36","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1161\/01.ATV.0000204334.48195.6a","article-title":"Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization","volume":"26","author":"Sandberg","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jvs.2009.07.119_bib37","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jacc.2007.09.058","article-title":"Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes","volume":"51","author":"Omland","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2009.07.119_bib38","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/01.CIR.0000127957.43874.BB","article-title":"Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease","volume":"109","author":"Kiechl","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2009.07.119_bib39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bcp.2006.09.007","article-title":"Statins decrease TNF-alpha-induced osteoprotegerin production by endothelial cells and smooth muscle cells in vitro","volume":"73","author":"Ben-Tal Cohen","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jvs.2009.07.119_bib40","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.2337\/dc07-0919","article-title":"Simvastatin reduces plasma osteoprotegerin in type 2 diabetic patients with microalbuminuria","volume":"30","author":"Nellemann","year":"2007","journal-title":"Diabetes Care"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521409016152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521409016152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:14:43Z","timestamp":1760040883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521409016152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0741521409016152"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2009.07.119","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2009.07.119","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}